In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
FluoroPharma Expands Technology Platform to Include Agents for Alzheimer’s Disease (AD)
TorreyPines Therapeutics Sells Alzheimer’s Disease Genetics Program to Eisai
SENEXIS TO COLLABORATE WITH ALZHYME ON ALZHEIMER’S DIAGNOSTICS
Molecular Sensing, Inc. and VIB Enter Agreement in Alzheimer’s Disease Research
GE and Genometrix Combine to Advance Disease Diagnosis
BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER’S DISEASE